Aurobindo moves to dismiss Walmart's US generic drug price-fixing claims
( September 3, 2025, 22:39 GMT | Official Statement) -- MLex Summary: Aurobindo Pharma asked a Pennsylvania federal judge to dismiss generic drug price-fixing claims brought by Walmart. "In attempting to cram as many Defendants and Drugs as possible into its Complaint, Plaintiff Walmart, Inc. (“Walmart”) failed to include factual allegations against Defendant Aurobindo Pharma USA, Inc. (“Aurobindo”) to support three drug-specific conspiracy claims," Aurobindo said in a motion to dismiss filed in the Eastern District of Pennsylvania.See attached document....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.